Breast cancer: further metabolic-endocrine risk markers?
1997

Breast Cancer and Risk Markers

publication

Author Information

Author(s): BA Stoll

Primary Institution: The Department of Oncology, St Thomas' Hospital, London SE1 7EH, UK

Hypothesis

Increased oestrogen receptor expression in normal mammary epithelium may be a risk marker for the development of breast cancer.

Conclusion

The study suggests that the combined effect of oestradiol and IGF1 may stimulate proliferation in normal mammary epithelium and increase breast cancer risk.

Supporting Evidence

  • Increased oestrogen receptor expression may indicate a higher risk of breast cancer.
  • Insulin-like growth factor 1 (IGF1) can promote the growth of breast cancer cells.
  • Hyperinsulinaemia is associated with higher IGF1 levels and may be a risk marker for breast cancer.

Takeaway

This study looks at how certain hormones and proteins might increase the risk of breast cancer by making breast cells grow more. If we understand these markers better, we can find ways to help women at risk.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication